Skip to content

Mannkind MNKD Goodwill

Goodwill at other companies

Eli Lilly logo
Eli LillyLLY
$6.13B+6.2%
LQD
Liquidia CorporationLQDA
$3.9M0.0%
Tenet Healthcare logo
Tenet HealthcareTHC
$11.39B+5.6%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$44.54M0.0%
Omada Health, Inc. Common Stock logo
Omada Health, Inc. Common StockOMDA
$13.24M
Merit Medical Systems logo
Merit Medical SystemsMMSI
$503.43M+8.4%

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's goodwill?
Mannkind (MNKD) reported goodwill of $67.6M in Q1 2026.
How has Mannkind's goodwill changed year-over-year?
Mannkind's goodwill increased by 3400.5% year-over-year, from $1.93M to $67.6M.
What is the long-term trend for Mannkind's goodwill?
Over 3 years (2022 to 2025), Mannkind's goodwill has grown at a 203.1% compound annual growth rate (CAGR), from $2.43M to $67.6M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.